Meeting of the President's Council of Advisors on Science and Technology, 53029-53030 [05-17595]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 171 / Tuesday, September 6, 2005 / Notices
Topics for discussion include findings
on two congressionally mandated
studies: home health margins, and
payments for oncology drugs and
administration services in the Medicare
system. The Commission will also
discuss issues related to the Medicare
wage index, outpatient therapy, valuing
services in the physician fee schedule,
and physician resource use. The
Commission will also host a panel on
quality measures in managed care
organizations.
Agendas will be e-mailed
approximately one week prior to the
meeting. The final agenda will be
available on the Commission’s Web site
(https://www.medpac.gov).
This will be the last notice placed in
the Federal Register by the
Commission. We will continue to e-mail
meeting agendas, which you can sign up
to receive at https://www.medpac.gov.
They will also be posted on our Web
site. In addition, we will now e-mail a
meeting notice two weeks prior to the
meeting date. If you have any comments
on this action, please contact Annissa
McDonald at amcdonald@medpac.gov
or (202) 220–3700.
MedPAC’s address is: 601
New Jersey Avenue, NW., Suite 9000,
Washington, DC 20001. The telephone
number is (202) 220–3700.
ADDRESSES:
Mark E. Miller,
Executive Director.
[FR Doc. 05–17567 Filed 9–2–05; 8:45 am]
BILLING CODE 6820–BW–M
September 8, 2005 Public Hearing
OPIC’s Sunshine Act notice of its
Public Hearing in Conjunction with
each Board meeting was published in
the Federal Register (Volume 70,
Number 158, Page 48446) on August 17,
2005. No requests were received to
provide testimony or submit written
statements for the record; therefore,
OPIC’s public hearing in conjunction
with OPIC’s September 15, 2005 Board
of Directors meeting scheduled for 2
p.m. on September 8, 2005 has been
cancelled.
Contact Person For Information:
Information on the hearing cancellation
may be obtained from Connie M. Downs
at (202) 336–8438, via facsimile at (202)
218–0136, or via e-mail at
cdown@opic.gov.
13:21 Sep 02, 2005
Jkt 205001
BILLING CODE 3210–01–M
OVERSEAS PRIVATE INVESTMENT
CORPORATION
September 15, 2005 Board of Directors
Meeting
Time And Date: Thursday, September
15, 2005, 10 a.m. (Open Portion) 10:15
a.m. (Closed Portion).
Place: Offices of the Corporation,
Twelfth Floor Board Room, 1100 New
York Avenue, NW., Washington, DC.
Status: Meeting Open to the Public
from 10 a.m. to 10:15 a.m. Closed
portion will commence at 10:15 a.m.
(approx.).
Matters To Be Considered:
1. President’s Report.
2. Approval of July 28, 2005 Minutes
(Open Portion).
Further Matters To Be Considered:
(Closed to the Public 10:15 a.m.)
1. Proposed FY2007 Budget.
2. Finance Project—Russia.
3. Finance Project—Asia.
4. Finance Project—Eastern Europe
and Turkey.
5. Finance Project—Mexico.
6. Approval of July 28, 2005 Minutes
(Closed Portion).
7. Pending Major Projects.
8. Reports.
Contact Person For Information:
Information on the meeting may be
obtained from Connie M. Downs at (202)
336–8438.
Dated: September 1, 2005.
Connie M. Downs,
Corporate Secretary, Overseas Private
Investment Corporation.
[FR Doc. 05–17724 Filed 9–1–05; 2:13 pm]
OVERSEAS PRIVATE INVESTMENT
CORPORATION
VerDate Aug<18>2005
Dated: September 1, 2005.
Connie M. Downs,
OPIC Corporate Secretary.
[FR Doc. 05–17723 Filed 9–1–05; 2:13 pm]
BILLING CODE 3210–01–M
OFFICE OF SCIENCE AND
TECHNOLOGY POLICY
Meeting of the President’s Council of
Advisors on Science and Technology
ACTION:
Notice of meeting.
SUMMARY: This notice sets forth the
schedule and summary agenda for a
meeting of the President’s Council of
Advisors on Science and Technology
(PCAST), and describes the functions of
the Council. Notice of this meeting is
required under the Federal Advisory
Committee Act (FACA).
Dates and Place: September 20, 2005,
Washington, DC. The meeting will be
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
53029
held in Room 100 of the National
Academies Keck Center located at 500
Fifth Street, NW., Washington, DC
20001.
Type of Meeting: Open. Further
details on the meeting agenda will be
posted on the PCAST Web site at:
https://www.ostp.gov/PCAST/pcast.html.
Proposed Schedule and Agenda: The
President’s Council of Advisors on
Science and Technology is scheduled to
meet in open session on Tuesday,
September 20, 2005, at approximately 9
a.m. The PCAST is tentatively
scheduled to hear presentations on
research and commercialization
activities in the areas of
pharmacogenomics (or personalized
medicine) and alternative energy. These
are both areas in which PCAST may
undertake studies regarding the Federal
role in research and development and
the barriers and possible implications
surrounding widespread adoption. A
review and update of other PCAST
topics (e.g., nanotechnology) is also
tentatively scheduled to occur. This
session will end at approximately 5 p.m.
Additional information on the agenda
will be posted at the PCAST Web site at:
https://www.ostp.gov/PCAST/pcast.html.
Public Comments: There will be time
allocated for the public to speak on the
above agenda items. This public
comment time is designed for
substantive commentary on PCAST’s
work topics, not for business marketing
purposes. Please submit a request for
the opportunity to make a public
comment five (5) days in advance of the
meeting. The time for public comments
will be limited to no more than 5
minutes per person. Written comments
are also welcome at any time following
the meeting. Please notify Celia
Merzbacher, PCAST Executive Director,
at (202) 456–7116, or fax your request/
comments to (202) 456–6021.
FOR FURTHER INFORMATION CONTACT: For
information regarding time, place and
agenda, please call Celia Merzbacher at
(202) 456–7116, prior to 3 p.m. on
Friday, September 16, 2005. Information
will also be available at the PCAST Web
site at: https://www.ostp.gov/PCAST/
pcast.html. Please note that public
seating for this meeting is limited and
is available on a first-come, first-served
basis.
SUPPLEMENTARY INFORMATION: The
President’s Council of Advisors on
Science and Technology was
established by Executive Order 13226,
on September 30, 2001. The purpose of
PCAST is to advise the President on
matters of science and technology
policy, and to assist the President’s
National Science and Technology
E:\FR\FM\06SEN1.SGM
06SEN1
53030
Federal Register / Vol. 70, No. 171 / Tuesday, September 6, 2005 / Notices
Council in securing private sector
participation in its activities. The
Council members are distinguished
individuals appointed by the President
from non-Federal sectors. The PCAST is
co-chaired by Dr. John H. Marburger, III,
the Director of the Office of Science and
Technology Policy, and by E. Floyd
Kvamme, a Partner at Kleiner Perkins
Caufield & Byers.
The proposed amendment to the
Linkage Plan was published in the
Federal Register on July 27, 2005.4 No
comments were received on the
proposed amendment. This order
approves the proposed amendment to
the Linkage Plan.
Stanley S. Sokul,
General Counsel, Office of Science and
Technology Policy.
[FR Doc. 05–17595 Filed 9–2–05; 8:45 am]
The purpose of the Joint Amendment
is to modify the 80/20 Test contained in
Section 8(b)(iii) of the Linkage Plan,
which provides that market makers
should send Principal Orders through
the Linkage on a limited basis and not
as a primary aspect of their business.
The 80/20 Test implements this general
principle by prohibiting a market maker
from sending Principal Orders in an
eligible option class if, in the last
calendar quarter, the market maker’s
Principal Order contract volume is
disproportionate to the market maker’s
contract volume executed against
customer orders in its own market.
The Participants have expressed
concern that the application of the 80/
20 Test has resulted in anomalies for
market makers with limited volume in
an eligible option class. Specifically, if
a market maker has very little overall
trading volume in an option, the
execution of one or two Principal
Orders during a calendar quarter could
result in the market maker failing to
meet the 80/20 Test. This would bar the
market maker from using the Linkage to
send Principal Orders for the following
calendar quarter. The Participants
contend that it was not their intent to
bar market makers with limited volume
from sending Principal Orders through
the Linkage in these circumstances
since such trading clearly was not ‘‘a
primary aspect of their business.’’ Thus,
in Joint Amendment No. 17, the
Participants propose to create a de
minimis exemption from the 80/20 Test
for market makers that have total
contract volume of less than 1,000
contracts in an options class for a
calendar quarter.
BILLING CODE 3170–W4–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–52350; File No. 4–429]
Joint Industry Plan; Order Approving
Amendment No. 17 to the Plan for the
Purpose of Creating and Operating an
Intermarket Option Linkage Regarding
Modifying the 80/20 Test for
Determining Limitations on Principal
Order Access to Linkage
August 26, 2005.
I. Introduction
On April 20, 2005, May 20, 2005, May
12, 2005, April 13, 2005, April 27, 2005
and May 11, 2005, the American Stock
Exchange LLC (‘‘Amex’’), the Boston
Stock Exchange, Inc. (‘‘BSE’’), the
Chicago Board Options Exchange,
Incorporated (‘‘CBOE’’), the
International Securities Exchange
(‘‘ISE’’), the Pacific Exchange, Inc.
(‘‘PCX’’), and the Philadelphia Stock
Exchange, Inc. (‘‘Phlx’’) (collectively,
‘‘Participants’’), respectively, filed with
the Securities and Exchange
Commission (‘‘Commission’’) Joint
Amendment No. 17 to the Plan for the
Purpose of Creating and Operating an
Intermarket Option Linkage (‘‘Linkage
Plan’’).1 In Joint Amendment No. 17, the
Participants propose to modify the 80/
20 Test to determine limitations on
Principal Order 2 access to Linkage.3
1 On July 28, 2000, the Commission approved a
national market system plan for the purpose of
creating and operating an intermarket options
market linkage (‘‘Linkage’’) proposed by Amex,
CBOE, and ISE. See Securities Exchange Act
Release No. 43086 (July 28, 2000), 65 FR 48023
(August 4, 2000). Subsequently, Phlx, PCX, and BSE
joined the Linkage Plan. See Securities Exchange
Act Release Nos. 43573 (November 16, 2000), 65 FR
70851 (November 28, 2000); 43574 (November 16,
2000), 65 FR 70850 (November 28, 2000); and 49198
(February 5, 2004), 69 FR 7029 (February 12, 2004).
2 A ‘‘Principal Order’’ is an order for the principal
account of an eligible market maker that does not
relate to a customer order the market maker is
holding. See Section 2(16)(b) of the Linkage Plan.
3 Specified in Section 8(b)(iii) of the Linkage Plan.
VerDate Aug<18>2005
13:21 Sep 02, 2005
Jkt 205001
II. Description and Purpose of the
Proposed Amendment
III. Discussion
After careful consideration, the
Commission finds that the proposed
amendment to the Linkage Plan seeking
to create a de minimis exception to the
80/20 Test is consistent with the
requirements of the Act and the rules
and regulations thereunder.
Specifically, the Commission finds that
the proposed amendment to the Linkage
Plan is consistent with Section 11A of
4 See Securities Exchange Act Release No. 52074
(July 20, 2005), 70 FR 43469.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
the Act 10 and Rule 11Aa3–2
thereunder,11 in that it will increase the
availability of Linkage to members of
the Participants by limiting the
applicability of the 80/20 Test in
situations where market makers have
minimal trading volume in a particular
options class.
The Commission recognizes that the
Participants do not believe that it is
necessary to bar market makers with
limited volume from sending Principal
Orders through the Linkage, as such
trading does not raise concerns that a
member is sending such orders as ‘‘a
primary aspect of their business.’’ The
Commission believes that the de
minimis exemption from the 80/20 Test
proposed by the Participants for market
makers that have total contract volume
of less than 1,000 contracts in an
options class for a calendar quarter
should ensure that market makers with
relatively low volume in a particular
options class can send a reasonable
number of Principal Orders without
being barred by application of the 80/20
Test from using the Linkage in the
following calendar quarter.
IV. Conclusion
It is therefore ordered, pursuant to
Section 11A of the Act 12 and Rule
11Aa3–2 thereunder,13 that the
proposed Joint Amendment No. 17 is
hereby approved.
For the Commission, by the Division of
Market Regulation, pursuant to delegated
authority.14
Margaret H. McFarland,
Deputy Secretary.
[FR Doc. E5–4835 Filed 9–2–05; 8:45 am]
BILLING CODE 8010–01–P
SECURITIES AND EXCHANGE
COMMISSION
Sunshine Act Meeting
Notice is hereby given, pursuant to
the provisions of the Government in the
Sunshine Act, Pub. L. 94–409, that the
Securities and Exchange Commission
will hold the following meeting during
the week of September 5, 2005:
A Closed Meeting will be held on
Wednesday, September 7, 2005 at 10
a.m.
Commissioners, Counsel to the
Commissioners, the Secretary to the
Commission, and recording secretaries
will attend the Closed Meeting. Certain
10 15
U.S.C. 78k–1.
CFR 240.11Aa3–2.
12 15 U.S.C. 78k–1.
13 17 CFR 240.11Aa3–2.
14 17 CFR 200.30–3(a)(29).
11 17
E:\FR\FM\06SEN1.SGM
06SEN1
]]>Agencies
[Federal Register Volume 70, Number 171 (Tuesday, September 6, 2005)]
[Notices]
[Pages 53029-53030]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-17595]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF SCIENCE AND TECHNOLOGY POLICY
Meeting of the President's Council of Advisors on Science and
Technology
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice sets forth the schedule and summary agenda for a
meeting of the President's Council of Advisors on Science and
Technology (PCAST), and describes the functions of the Council. Notice
of this meeting is required under the Federal Advisory Committee Act
(FACA).
Dates and Place: September 20, 2005, Washington, DC. The meeting
will be held in Room 100 of the National Academies Keck Center located
at 500 Fifth Street, NW., Washington, DC 20001.
Type of Meeting: Open. Further details on the meeting agenda will
be posted on the PCAST Web site at: https://www.ostp.gov/PCAST/
pcast.html.
Proposed Schedule and Agenda: The President's Council of Advisors
on Science and Technology is scheduled to meet in open session on
Tuesday, September 20, 2005, at approximately 9 a.m. The PCAST is
tentatively scheduled to hear presentations on research and
commercialization activities in the areas of pharmacogenomics (or
personalized medicine) and alternative energy. These are both areas in
which PCAST may undertake studies regarding the Federal role in
research and development and the barriers and possible implications
surrounding widespread adoption. A review and update of other PCAST
topics (e.g., nanotechnology) is also tentatively scheduled to occur.
This session will end at approximately 5 p.m. Additional information on
the agenda will be posted at the PCAST Web site at: https://
www.ostp.gov/PCAST/pcast.html.
Public Comments: There will be time allocated for the public to
speak on the above agenda items. This public comment time is designed
for substantive commentary on PCAST's work topics, not for business
marketing purposes. Please submit a request for the opportunity to make
a public comment five (5) days in advance of the meeting. The time for
public comments will be limited to no more than 5 minutes per person.
Written comments are also welcome at any time following the meeting.
Please notify Celia Merzbacher, PCAST Executive Director, at (202) 456-
7116, or fax your request/comments to (202) 456-6021.
FOR FURTHER INFORMATION CONTACT: For information regarding time, place
and agenda, please call Celia Merzbacher at (202) 456-7116, prior to 3
p.m. on Friday, September 16, 2005. Information will also be available
at the PCAST Web site at: https://www.ostp.gov/PCAST/pcast.html. Please
note that public seating for this meeting is limited and is available
on a first-come, first-served basis.
SUPPLEMENTARY INFORMATION: The President's Council of Advisors on
Science and Technology was established by Executive Order 13226, on
September 30, 2001. The purpose of PCAST is to advise the President on
matters of science and technology policy, and to assist the President's
National Science and Technology
[[Page 53030]]
Council in securing private sector participation in its activities. The
Council members are distinguished individuals appointed by the
President from non-Federal sectors. The PCAST is co-chaired by Dr. John
H. Marburger, III, the Director of the Office of Science and Technology
Policy, and by E. Floyd Kvamme, a Partner at Kleiner Perkins Caufield &
Byers.
Stanley S. Sokul,
General Counsel, Office of Science and Technology Policy.
[FR Doc. 05-17595 Filed 9-2-05; 8:45 am]
BILLING CODE 3170-W4-P
